Defining "success" in recruitment of underrepresented populations to cancer clinical trials: moving toward a more consistent approach (Q36384604)

13 August 2017

1 reference

title

Defining "success" in recruitment of underrepresented populations to cancer clinical trials: moving toward a more consistent approach (English)

1 reference

13 August 2017

10

Eric Bass

1 reference

13 August 2017

Shari Bolen

1

1 reference

13 August 2017

Jon Tilburt

2

1 reference

13 August 2017

Charlie Baffi

3

1 reference

13 August 2017

Tiffany L Gary

4

1 reference

13 August 2017

Neil Powe

5

1 reference

13 August 2017

Mollie Howerton

6

1 reference

13 August 2017

Jean Ford

7

1 reference

13 August 2017

Gabriel Lai

8

1 reference

13 August 2017

Renee Wilson

9

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

13 August 2017

1 reference

13 August 2017

106

1 reference

13 August 2017

6

1 reference

13 August 2017

1197-1204

1 reference

Racial disparities in breast carcinoma survival rates: seperating factors that affect diagnosis from factors that affect treatment

13 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21745

Selection and description of cancer clinical trials participants--science or happenstance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21745

Recruitment strategies for cervical cancer prevention study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21745

A report on accrual rates for elderly and minority-ethnicity cancer patients to clinical trials of the American College of Surgeons Oncology Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21745

A randomized trial of recruitment methods for older African American men in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21745

Barriers to clinical trial participation by older women with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21745

Oncologists' reluctance to accrue patients onto clinical trials: an Illinois Cancer Center study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21745

Participation of patients 65 years of age or older in cancer clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21745

Factors associated with breast cancer clinical trials participation and enrollment at a large academic medical center

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21745

Household smoking behavior and ETS exposure among children with asthma in low-income, minority households

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21745

Recruitment and retention of economically underserved women to a cervical cancer prevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21745

Psychopharmacological research ethics: special issues affecting US ethnic minorities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21745

Attitudes and beliefs of African Americans toward participation in medical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21745

Interpretations of 'appropriate' minority inclusion in clinical research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21745

Existing data on breast cancer in African-American women: what we know and what we need to know

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21745

21 January 2018

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21745

7 January 2021

Cancer disparities by race/ethnicity and socioeconomic status

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21745

7 January 2021

How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21745

7 January 2021

The study of tamoxifen and raloxifene: preliminary enrollment data from a randomized breast cancer risk reduction trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21745

7 January 2021

Clinical trial enrollment of rural patients with cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21745

7 January 2021

Participation and Adherence Among Older Men and Women Recruited to the Beta-Carotene and Retinol Efficacy Trial (CARET)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21745

7 January 2021

Assuring access to state-of-the-art care for U.S. minority populations: the first 2 years of the Minority-Based Community Clinical Oncology Program.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21745

7 January 2021

Challenges to improving the impact of worksite cancer prevention programs: comparing reach, enrollment, and attrition using active versus passive recruitment strategies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21745

7 January 2021

Enrollment of Older Patients in Cancer Treatment Trials in Canada: Why is Age a Barrier?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21745

7 January 2021

Representation of Asian Americans in clinical cancer trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21745

7 January 2021

Cancer treatment protocols. Who gets chosen?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21745

7 January 2021

ASCUS-LSIL Triage Study. Design, methods and characteristics of trial participants

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21745

7 January 2021

Underrepresentation of patients 65 years of age or older in cancer-treatment trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21745

7 January 2021

Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21745

7 January 2021

Representation of older patients in cancer treatment trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21745

7 January 2021

Patterns of enrollment on cooperative group studies. An analysis of trends from the Los Angeles County Cancer Surveillance Program

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21745

7 January 2021

Participation in cancer clinical trials: race-, sex-, and age-based disparities

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21745

7 January 2021

Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21745

7 January 2021

Minority recruitment in the prostate cancer prevention trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21745

7 January 2021

Factors influencing enrollment in clinical trials for cancer treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21745

7 January 2021

African American community health advisors trained as research partners: recruitment and training

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21745

7 January 2021

Issues of recruitment, retention, and compliance in community-based clinical trials with traditionally underserved populations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21745

7 January 2021

Clinical trial participation. Viewpoints from racial/ethnic groups

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21745

7 January 2021

Identifiers

DOI

10.1002/CNCR.21745

1 reference

13 August 2017

1 reference